Filing Flows

Filing Flows › Collegium Pharmaceutical (COLL) › Who owns the stock

Who owns Collegium Pharmaceutical (COLL) stock

261 funds reported Collegium Pharmaceutical (COLL) shares in their latest 13F filings, worth $1.5B in all. The largest holder is BlackRock ($197M). Last quarter 148 funds added to their stakes and 101 cut them.

Largest holders of COLL (13F)Largest holders of COLL (13F)BlackRock$197MVanguard Group$104MJupiter Topco LLC$77.7MInvesco$68.1MJanus Henderson Group$60.4MFuller & Thaler Asset Management$59.1MPrincipal Financial Group$59.1MState Street$55.3MMassachusetts Financial Services$50.9MVanguard Capital Management LLC$50.0M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock5,441,202$197Mincrease2026-06-30
Vanguard Group2,256,254$104Mincrease2025-12-31
Jupiter Topco LLC2,147,072$77.7Mbase2026-06-30
Invesco1,882,499$68.1Mincrease2026-06-30
Janus Henderson Group1,825,651$60.4Mincrease2026-03-31
Fuller & Thaler Asset Management1,632,781$59.1Mincrease2026-06-30
Principal Financial Group1,632,360$59.1Mincrease2026-06-30
State Street1,528,881$55.3Mincrease2026-06-30
Massachusetts Financial Services1,405,567$50.9Mincrease2026-06-30
Vanguard Capital Management LLC1,381,261$50.0Mincrease2026-06-30
Renaissance Technologies LLC1,366,549$49.5Mdecrease2026-06-30
Eventide Asset Management, LLC1,361,228$49.3Mdecrease2026-06-30
Rubric Capital Management LP1,279,611$46.3Munchanged2026-06-30
Geode Capital Management, LLC890,886$32.3Mincrease2026-06-30
Dimensional Fund Advisors LP837,877$30.3Mincrease2026-06-30

Collegium Pharmaceutical's latest quarter

Collegium Pharmaceutical, Q3 2026: revenue $216M (+3% year over year), operating margin 13.3%, net earnings $21.8M, operating cash flow $86.5M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most COLL stock?

By the latest 13F filings: BlackRock ($197M); Vanguard Group ($104M); Jupiter Topco LLC ($77.7M); Invesco ($68.1M); Janus Henderson Group ($60.4M).

What is the short interest in COLL?

5,375,283 shares were sold short at the 2026-10-15 settlement, -2.57% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.